Short Interest in Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) Decreases By 8.9%

Posted by Jeff Wilder on Jul 16th, 2024

Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF – Get Free Report) saw a significant decline in short interest in June. As of June 30th, there was short interest totalling 298,400 shares, a decline of 8.9% from the June 15th total of 327,400 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Hua Medicine (Shanghai) Stock Performance

OTCMKTS:HUMDF remained flat at C$0.20 during mid-day trading on Tuesday. Hua Medicine has a 12 month low of C$0.20 and a 12 month high of C$0.20. The firm has a 50 day moving average price of C$0.20 and a 200-day moving average price of C$0.20.

Hua Medicine (Shanghai) Company Profile

(Get Free Report)

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D.